MAS1 and acquired idiopathic inflammatory myopathy: Autoantibodies in patients with IIM, i.e., myositis autoantibodies (MAs), can be further classified into myositis-specific autoantibodies (MSAs), detected uniquely in two of three patients with IIM presenting specific phenotypes (9) among each MSA and mutually exclusive to one another.